Tenofovir alafenamide for HBV Patients

We need to tenofovir alafenamide for HBV patients now in Iran! The US Food and Drug Administration has approved tenofovir alafenamide (TAF) 25 mg once daily, for treatment of adults with chronic hepatitis B virus (HBV) infection with compensated liver disease. Tenofovir disoproxil fumarate (TDF) has potent antiviral activity in…

Read More